Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study von Rudin, Charles M, Prof, Pietanza, M Catherine, MD, Bauer, Todd M, MD, Ready, Neal, Prof, Morgensztern, Daniel, MD, Glisson, Bonnie S, Prof, Byers, Lauren A, MD, Johnson, Melissa L, MD, Burris, Howard A, MD, Robert, Francisco, Prof, Han, Tae H, PhD, Bheddah, Sheila, BA, Theiss, Noah, MS, Watson, Sky, BS, Mathur, Deepan, MD, Vennapusa, Bharathi, MD, Zayed, Hany, PhD, Lally, Satwant, MS, Strickland, Donald K, MD, Govindan, Ramaswamy, Prof, Dylla, Scott J, PhD, Peng, Stanford L, MD, Spigel, David R, MD

Volltext

The engineered CD80 variant fusion therapeutic davoceticept combines checkpoint antagonism with conditional CD28 costimulation for anti-tumor immunity von Maurer, Mark F., Lewis, Katherine E., Kuijper, Joseph L., Ardourel, Dan, Gudgeon, Chelsea J., Chandrasekaran, Siddarth, Mudri, Sherri L., Kleist, Kayla N., Navas, Chris, Wolfson, Martin F., Rixon, Mark W., Swanson, Ryan, Dillon, Stacey R., Levin, Steven D., Kimbung, Yengo Raymond, Akutsu, Masato, Logan, Derek T., Walse, Björn, Swiderek, Kristine M., Peng, Stanford L.

Volltext

MOLECULAR MECHANISMS REGULATING TH1 IMMUNE RESPONSES von Szabo, Susanne J, Sullivan, Brandon M, Peng, Stanford L, Glimcher, Laurie H

Volltext

Inflammatory arthritis requires Foxo3a to prevent Fas ligand-induced neutrophil apoptosis von Peng, Stanford L, Jonsson, Helena, Allen, Paul

Volltext

Type I IFN Protects Against Murine Lupus von Hron, Jonathan D, Peng, Stanford L

Volltext

FOXO3 regulates CD8 T cell memory by T cell-intrinsic mechanisms von Sullivan, Jeremy A, Kim, Eui Ho, Plisch, Erin H, Peng, Stanford L, Suresh, M

Volltext

T-bet Regulates IgG Class Switching and Pathogenic Autoantibody Production von Peng, Stanford L., Szabo, Susanne J., Glimcher, Laurie H.

Volltext

Forkhead Box, Class O Transcription Factors in Brain: Regulation and Behavioral Manifestation von Polter, Abigail, Yang, Sufen, Zmijewska, Anna A, van Groen, Thomas, Paik, Ji-Hye, DePinho, Ronald A, Peng, Stanford L, Jope, Richard S, Li, Xiaohua

Volltext

Case report of fatal immune-mediated myocarditis following treatment with davoceticept (ALPN-202), a PD-L1-dependent CD28 costimulator and dual PD-L1/CTLA-4 checkpoint inhibitor, i... von Cavalcante, Ludimila, Chandana, Sreenivasa, Lakhani, Nehal, Enstrom, Amanda, LeBlanc, Heidi, Schmalz, Joseph, Lengyel, Krisztina, Schneider, Frank, Thomas, Heather, Chisamore, Michael J, Peng, Stanford L, Naumovski, Allison, Davar, Diwakar

Volltext

CpG DNA redirects class‐switching towards "Th1‐like" Ig isotype production via TLR9 and MyD88 von Lin, Ling, Gerth, Andrea J., Peng, Stanford L.

Volltext

First‐in‐human study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of ALPN‐101, a dual CD28/ICOS antagonist, in healthy adult subjects von Yang, Jing, Lickliter, Jason D., Hillson, Jan L., Means, Gary D., Sanderson, Russell J., Carley, Kay, Tercero, Almudena, Manjarrez, Kristi L., Wiley, Jennifer R., Peng, Stanford L.

Volltext

The T-box Transcription Factor T-bet in Immunity and Autoimmunity von Peng, Stanford L

Volltext

Phase I studies of davoceticept (ALPN-202), a PD-L1-dependent CD28 co-stimulator and dual PD-L1/CTLA-4 inhibitor, as monotherapy and in combination with pembrolizumab in advanced s... von Davar, Diwakar, Cavalcante, Ludimila, Lakhani, Nehal, Moser, Justin, Millward, Michael, McKean, Meredith, Voskoboynik, Mark, Sanborn, Rachel E, Grewal, Jaspreet S, Narayan, Ajita, Patnaik, Amita, Gainor, Justin F, Sznol, Mario, Enstrom, Amanda, Blanchfield, Lori, LeBlanc, Heidi, Thomas, Heather, Chisamore, Michael J, Peng, Stanford L, Naumovski, Allison

Volltext

Novel Immunomodulatory Proteins Generated via Directed Evolution of Variant IgSF Domains von Levin, Steven D., Evans, Lawrence S., Bort, Susan, Rickel, Erika, Lewis, Katherine E., Wu, Rebecca P., Hoover, Joseph, MacNeil, Sean, La, David, Wolfson, Martin F., Rixon, Mark W., Dillon, Stacey R., Kornacker, Michael G., Swanson, Ryan, Peng, Stanford L.

Volltext

TBX21: A Functional Variant Predicts Improvement in Asthma with the Use of Inhaled Corticosteroids von Tantisira, Kelan G, Hwang, Eun Sook, Raby, Benjamin A, Silverman, Eric S, Lake, Stephen L, Richter, Brent G, Peng, Stanford L, Drazen, Jeffrey M, Glimcher, Laurie H, Weiss, Scott T

Volltext

The Relapsing Polychondritis Disease Activity Index: Development of a disease activity score for relapsing polychondritis von Arnaud, Laurent, Devilliers, Hervé, Peng, Stanford L, Mathian, Alexis, Costedoat-Chalumeau, Nathalie, Buckner, Jane, Dagna, Lorenzo, Michet, Clement, Sharma, Aman, Cervera, Ricard, Haroche, Julien, Papo, Thomas, D'Cruz, David, Arlet, Philippe, Zwerina, Jochen, Belot, Alexandre, Suzuki, Noboru, Harle, Jean-Robert, Moots, Robert, Jayne, David, Hachulla, Eric, Marie, Isabelle, Tanaka, Toshio, Lebovics, Robert, Scott, David, Kucharz, Eugene J, Birchall, Martin, Kong, Kok Ooi, Gorochov, Guy, Amoura, Zahir

Volltext

Signaling in B cells via Toll-like receptors von Peng, Stanford L

Volltext

T‐bet regulates T‐independent IgG2a class switching von Gerth, Andrea J., Lin, Ling, Peng, Stanford L.

Volltext

Active inhibition of plasma cell development in resting B cells by microphthalmia-associated transcription factor von Lin, Ling, Gerth, Andrea J, Peng, Stanford L

Volltext

Forkhead transcription factors in chronic inflammation von Peng, Stanford L.

Volltext